MedPath

Single Embryo Transfer Versus Double Embryo Transfer

Not Applicable
Terminated
Conditions
Infertility
Registration Number
NCT00814398
Lead Sponsor
IVI Sevilla
Brief Summary

The aim of this project is to study the best number (1 or 2)and day (3 vs 5)of embryo transfer in good prognosis patient.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
199
Inclusion Criteria

G

  • Good prognosis IVF patients
Exclusion Criteria
  • Bad prognosis IVF patients

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Live-birth delivery rateEnd of pregnancy (nine months after last transfer)
Secondary Outcome Measures
NameTimeMethod
Acceptance of assigned randomised groupDay of randomisation
Multiple live-birth rateEnd of pregnancy (nine months after last transfer)

Trial Locations

Locations (1)

IVI-Sevilla

🇪🇸

Seville, Spain

IVI-Sevilla
🇪🇸Seville, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.